Skip to content
  • About
    • About Us
    • Our Team
  • Technology
    • Omira™ Discovery
    • Omira™ OC
  • Publications
  • News
  • Exit Report
  • Careers
  • Contact
AOA-logo-white

Day: October 6, 2026

AOA Dx Builds Oncology Platform Across Three Gynecologic Cancers as Lead Ovarian Cancer Assay Advances Toward Commercialization

Study demonstrates that integrating lipids, metabolites, and proteins reveals coordinated molecular signatures missed by traditional single omic tests. 

Legal

Copyright 2020 – 2026

Privacy Policy

Contact

info@aoadx.com

press@aoadx.com

careers@aoadx.com

6860 Broadway, Unit B, Denver CO 80221

Follow
Instagram Linkedin Twitter

Website by Sungraphic